Recommended videos you might also like
08:40
Case Discussion: CTO In high risk patient with Impella support.
![](https://reachora-public-videos.imgix.net/v/24/3/c/dd8f3e-e574-4810-83d7-e03dab861ef5/thumbnails/image_1.jpg)
00:33
What are the advantages of RDN over pharmacological therapy?
![](https://reachora-public-videos.imgix.net/v/12/0/b/a2e370-1fe3-43f4-9f51-b373ef6ccbc9/thumbnails/image_0.jpg)
01:13
What are the key results of the Spyral studies?
![](https://reachora-public-videos.imgix.net/v/12/6/9/90562d-97e6-425a-ad2a-33e7089f8193/thumbnails/image_0.jpg)
00:54
Which Patients are most likely to be receptive to RDN?
![](https://reachora-public-videos.imgix.net/v/12/f/6/a4768f-3cec-476c-b764-9766b43e36a8/thumbnails/image_0.jpg)
00:36
How does RDN work?
![](https://reachora-public-videos.imgix.net/v/12/1/0/895824-ad73-44df-b58a-e5a0148ccba9/thumbnails/image_0.jpg)
00:49
What is needed for widespread adoption of RDN?
![](https://reachora-public-videos.imgix.net/v/12/c/9/025dc2-0186-4b9b-a127-9191d7443071/thumbnails/image_0.jpg)
Where does renal denervation fit into current clinical practice?
![](https://rutherford-public-images.imgix.net/channels/logo_images/c62d4e36ab8e56a5a12b1d310e73d01d.jpg?height=96)
HTN:RDN
427 videos
Sharing knowledge of renal denervation (RDN) as a new device-based therapy for control of raised blood pressure
Start a conversation